NCT06908252CompletedPhase 4
MAPS PrEP Van Study
Integrating PrEP Into Mobile Addiction and Primary Care Services (MAPS)
Source: ClinicalTrials.gov · Last updated 24 Jul 2026
Brief summary (registry, in English)
For this study the investigators aim to see if giving participants an oral HIV prevention medication on a medical van, is a good option of care for individuals who inject drugs and/or are sexually active and therefore at a higher risk of contracting HIV.
- Status (registry)
- Completed
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 7 (actual)
- First submitted
- 20 Mar 2025
- Start date
- 17 Sept 2025
- Primary completion date
- 13 May 2026
- Lead sponsor
- Duke University
- Diseases
- HIV
- NCT number
- NCT06908252
What you commit to
- Study type: Interventional · Phase 4
- Participants enrolled: 7
- From 17 Sept 2025 to the primary completion date, 13 May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- positive HIV status
Who the study is looking for
- 18 years or older, active drug injection user and/or sexually active, referred from the Syringe Service Program
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Duke Department of Population Health Sciences Coordinator of this site? Confirm its status | Durham | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.